Literature DB >> 33571915

Autonomic dysregulation as an early pathologic feature of Huntington Disease.

Jordan L Schultz1, Lyndsay A Harshman2, John A Kamholz3, Peg C Nopoulos4.   

Abstract

OBJECTIVE: Autonomic nervous system (ANS) dysfunction has been described in adults with motor-manifest Huntington's Disease (HD) or those who are near their predicted motor onset. It is unclear if ANS dysfunction is present years prior to the onset of motor symptoms of HD. To bridge this gap in knowledge, we compared crude markers of ANS function between children with the gene-expansion that causes HD (GE group) who were decades from their predicted motor onset and gene-non-expanded children (GNE group).
METHODS: We included participants from the Kids-HD study who were <18 years old. Linear mixed effects regression models were constructed that controlled for sex, age, and BMI, and included a random effect per participant and per family. We compared resting heart rate (rHR), core body temperature (CBT), systolic blood pressure (SBP), and diastolic blood pressure (DBP) between the GE (n = 84) and GNE (n = 238) groups. We then grouped participants from the GE group based on their predicted years to onset (YTO) and compared their vital signs to the GNE group.
RESULTS: The GE group had higher rHR (∆ = 3.83, p = 0.0064), SBP (∆ = 2.38, p = 0.032), and CBT (∆ = 0.16, t = 2.92, p = 0.007). The mean rHR and CBT became significantly elevated compared to the GNE group in participants who had 15-25 YTO and those who had <15 YTO. The mean SBP of participants who had 25-35 YTO was significantly elevated compared to the GNE group.
CONCLUSION: ANS dysfunction in HD seems to occur approximately 20 years prior to the predicted onset of motor symptoms of HD.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autonomic nervous system; Blood pressure; Heart rate; Huntington Disease; Temperature

Mesh:

Year:  2021        PMID: 33571915      PMCID: PMC8176778          DOI: 10.1016/j.autneu.2021.102775

Source DB:  PubMed          Journal:  Auton Neurosci        ISSN: 1566-0702            Impact factor:   3.145


  20 in total

1.  Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study.

Authors:  Jane S Paulsen; Jeffrey D Long; Christopher A Ross; Deborah L Harrington; Cheryl J Erwin; Janet K Williams; Holly James Westervelt; Hans J Johnson; Elizabeth H Aylward; Ying Zhang; H Jeremy Bockholt; Roger A Barker
Journal:  Lancet Neurol       Date:  2014-11-03       Impact factor: 44.182

Review 2.  Hypothalamic and Limbic System Changes in Huntington's Disease.

Authors:  Asa Petersén; Sanaz Gabery
Journal:  J Huntingtons Dis       Date:  2012

3.  Risk stratification in hypertension: new insights from the Framingham Study.

Authors:  W B Kannel
Journal:  Am J Hypertens       Date:  2000-01       Impact factor: 2.689

Review 4.  Elevated heart rate: a major risk factor for cardiovascular disease.

Authors:  P Palatini; S Julius
Journal:  Clin Exp Hypertens       Date:  2004 Oct-Nov       Impact factor: 1.749

5.  Autonomic nervous system function in Huntington's disease.

Authors:  J Andrich; T Schmitz; C Saft; T Postert; P Kraus; J T Epplen; H Przuntek; M W Agelink
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-06       Impact factor: 10.154

6.  Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.

Authors:  Sarah J Tabrizi; Rachael I Scahill; Gail Owen; Alexandra Durr; Blair R Leavitt; Raymund A Roos; Beth Borowsky; Bernhard Landwehrmeyer; Chris Frost; Hans Johnson; David Craufurd; Ralf Reilmann; Julie C Stout; Douglas R Langbehn
Journal:  Lancet Neurol       Date:  2013-05-09       Impact factor: 44.182

7.  A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length.

Authors:  D R Langbehn; R R Brinkman; D Falush; J S Paulsen; M R Hayden
Journal:  Clin Genet       Date:  2004-04       Impact factor: 4.438

8.  Cognitive and autonomic dysfunction in presymptomatic and early Huntington's disease.

Authors:  Jan Kobal; Ziva Melik; Ksenija Cankar; Martin Strucl
Journal:  J Neurol       Date:  2014-04-02       Impact factor: 4.849

9.  Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington's disease Young Adult Study (HD-YAS): a cross-sectional analysis.

Authors:  Rachael I Scahill; Paul Zeun; Katherine Osborne-Crowley; Eileanoir B Johnson; Sarah Gregory; Christopher Parker; Jessica Lowe; Akshay Nair; Claire O'Callaghan; Christelle Langley; Marina Papoutsi; Peter McColgan; Carlos Estevez-Fraga; Kate Fayer; Henny Wellington; Filipe B Rodrigues; Lauren M Byrne; Amanda Heselgrave; Harpreet Hyare; Cristina Sampaio; Henrik Zetterberg; Hui Zhang; Edward J Wild; Geraint Rees; Trevor W Robbins; Barbara J Sahakian; Douglas Langbehn; Sarah J Tabrizi
Journal:  Lancet Neurol       Date:  2020-05-26       Impact factor: 44.182

10.  Autonomic disorders and myocardial 123I-metaiodobenzylguanidine scintigraphy in Huntington's disease.

Authors:  Roberta Assante; Elena Salvatore; Carmela Nappi; Silvio Peluso; Giovanni De Simini; Luigi Di Maio; Gianluigi Rosario Palmieri; Isabella Pia Ferrara; Alessandro Roca; Giuseppe De Michele; Alberto Cuocolo; Sabina Pappatà; Anna De Rosa
Journal:  J Nucl Cardiol       Date:  2020-08-16       Impact factor: 5.952

View more
  1 in total

Review 1.  Defining circadian disruption in neurodegenerative disorders.

Authors:  Christopher S Colwell
Journal:  J Clin Invest       Date:  2021-10-01       Impact factor: 19.456

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.